Innate versus adaptive immunity in Candida albicans infection

Immunology and Cell Biology

Volumn 82, Issue 2, 2004, Pages 196-204

  Ashman, Robert B ^a   Farah, Camile S ^b   Wanasaengsakul, Siripen ^b   Hu, Yan ^b   Pang, Gerald ^b   Clancy, Robert L ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b NONE

Author keywords

Cytokines; Oral candidiasis; Phagocytic cells; Systemic candidiasis; T cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

BONE MARROW; CANDIDA ALBICANS; CANDIDIASIS; CELL COUNT; CELL FUNCTION; CELLULAR IMMUNITY; DOWN REGULATION; GASTROINTESTINAL INFECTION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; INFECTION SENSITIVITY; MICROBIAL ACTIVITY; MOUTH INFECTION; MUCOCUTANEOUS CANDIDIASIS; NEUTROPHIL; NONHUMAN; PHAGOCYTE; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL; THRUSH; TISSUE INJURY;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; CANDIDIASIS, ORAL; DISEASE MODELS, ANIMAL; GASTROINTESTINAL DISEASES; HUMANS; IMMUNITY, ACTIVE; IMMUNITY, NATURAL; MICE; MICE, NUDE;

ANIMALIA; CANDIDA; CANDIDA ALBICANS; HUMAN IMMUNODEFICIENCY VIRUS; MURINAE;

EID: 2342614695     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0818-9641.2004.01217.x     Document Type: Review

References (75)

1. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 1991; 91: 72S-75S.
2. Kirkpatrick CH. Host factors in defense against fungal infections. Am. J. Med. 1984; 77: 1-12.
3. Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J. Pedlatr. 1989; 114: 555-60.
4. Parry MF, Root RK, Metcalf JA et al. Myeloperoxidase deficiency. Prevalence and clinical significance. Ann. Intern. Med. 1981; 95: 293-301.
5. Cole GT, Halawa AA, Anaissie EJ. The role of the gastrointestinal tract in hematogenous candidiasis: From the laboratory to the bedside. Clin. Infect. Dis 1996; 22: S73-88.
6. Papadimitriou JM, Ashman RB. The pathogenesis of acute systemic candidiasis in a susceptible inbred mouse strain. J. Pathol. 1986; 150: 257-65.
7. + T lymphocytes in recovery from oropharyngeal candidiasis. Infect. Immun. 2002; 70: 724-31.
8. Romani L. Immunity to Candida albicans: Th1, th2 cells and beyond. Curr. Opin. Microbiol. 1999; 2: 363-7.
9. + subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J. Immunol. 1993; 150: 925-31.
10. Ashman RB. Candida albicans: Pathogenesis, immunity and host defence. Res. Immunol. 1998; 149: 281-8.
11. Cutler JE. Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice. J. Reticuloendothel. Soc. 1976; 19: 121-4.
12. Rogers TJ, Balish E, Manning DD. The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis. J. Reticuloendothel Soc. 1976; 20: 291-8.
13. Mahanty S, Greenfield RA, Joyce WA, Kincade PW. Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome. Infect. Immun. 1988; 56: 3162-6.
14. + cells also demonstrate strain-specific immunopathological effects. Microbiology 1999; 145: 1631-40.
15. Ashman RB, Bolitho EM, Fulurija A. Cytokine mRNA in brain tissue from mice that show strain-dependent differences in the severity of lesions induced by systemic infection with Candida albicans yeast. J. Infect. Dis 1995; 172: 823-30.
16. Kirkpatrick CH, Rich RR, Bennett JE. Chronic mucocutaneous candidiasis: Model-building in cellular immunity. Ann. Intern. Med. 1971; 74: 955-78.
17. Klein RS, Harris CA, Small CB et al. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. New Engl. J. Med. 1984; 311: 354-8.
18. Leigh JE, Steele C, Wormley FL et al. Th1/th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals - a pilot study in HIV-positive individuals with oropharyngeal candidiasis. J. Acquir. Immun. Defic. Syndr. Human Retrovirol. 1998; 19: 373-80.
19. Leigh JE, Steele C, Wormley F, Fidel PL Jr. Salivary cytokine profiles in the immunocompetent individual with Candida-associated denture stomatitis. Oral Microbiol. Immunol. 2002; 17: 311-4.
20. Mohamed AM. Ultratructural aspects of chronic oral candidosis. J. Oral Pathol. 1975; 4: 180-94.
21. Crowe SM, Vardaxis NJ, Kent SJ et al. HIV infection of monocyte-derived macrophages in vitro reduces phagocytosis of Candidia albicans. J. Leukoc. Biol. 1994; 56: 318-27.
22. Davenport JC, Wilton JM. Incidence of immediate and delayed hypersensitivity of Candida albicans in denture stomatitis. J. Dent. Res. 1971; 50: 892-6.
23. Iacopino AM, Wathen WF. Oral Candidal infection and denture stomatitis: a comprehensive review. J. Am. Dent. Assoc. 1992; 123:46-51.
24. Balish E, Filutowicz H, Oberley TD. Correlates of cell-mediated immunity in Candida albicans-colonized gnotobiotic mice. Infect. Immun. 1990; 58: 107-13.
25. Domer JE. Intragastric colonization of infant mice with Candida albicans induces systemic immunity demonstrable upon challenge as adults. J. Infect. Dis 1988; 157: 950-8.
26. + lymphocytes in resistance to mucosal candidiasis. Infect. Immun. 1991; 59: 2447-55.
27. Cantorna MT, Balish E. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect. Immun. 1990; 58: 1093-100.
28. Narayanan R, Joyce WA, Greenfield RA. Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome. Infect. Immun. 1991; 59: 2116-9.
29. Cenci E, Mencacci A, Spaccapelo R et al. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J. Infect. Dis 1995; 171: 1279-88.
30. Bistoni F, Cenci E, Mencacci A et al. Mucosal and systemic T helper cell function after intragastric colonization of adult mice with Candida albicans. J. Infect. Dis 1993; 168: 1449-57.
31. Mencacci A, Cenci E, Del Sero G et al. Il-10 is required for development of protective Th1 responses in IL-12-deficient mice upon Candida albicans infection. J. Immunol. 1998; 161: 6228-37.
32. Puccetti P, Mencacci A, Cenci E et al. Cure of murine candidiasis by recombinant soluble interleukin-4 receptor. J. Infect. Dis 1994; 169: 1325-31.
33. Jones-Carson J, Vazquez-Torres FA, Balish E. B cell-independent selection of memory T cells after mucosal immunization with Candida albicans. J. Immunol. 1997; 158: 4328-35.
34. Jones-Carson J, Vazquez-Torres A, van der Heyde HC et al. γ/δ T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nature Med. 1995; 1: 552-7.
35. Jones-Carson J, Vazquez-Torres A, Warner T, Balish E. Disparate requirement for T cells in resistance to mucosal and acute systemic candidiasis. Infect. Immun. 2000; 68: 2363-5.
36. Balish E, Jensen J, Warner T, Brekke J, Leonard B. Mucosal and disseminated candidiasis in gnotobiotic SCID mice. J. Med. Vet. Mycol. 1993; 31: 143-54.
37. Jensen J, Vazquez-Torres A, Balish E. Poly(I.C)-induced interferons enhance susceptibility of SCID mice to systemic candidiasis. Infect. Immun. 1992; 60: 4549-57.
38. Jensen J, Warner T, Balish E. The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenic mice. J. Infect. Dis 1994; 170: 900-5.
39. Jensen J, Warner T, Balish E. Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: Role of polymorphonuclear leukocytes and macrophages. J. Infect. Dis 1993; 167: 912-9.
40. Vazquez-Torres A, Jones-Carson J, Warner T, Balish E. Nitric oxide enhances resistance of SCID mice to mucosal candidiasis. J. Infect. Dis 1995; 172: 192-8.
41. Vazquez-Torres A, Jones-Carson J, Balish E. Nitric oxide production does not directly increase macrophage candidacidal activity. Infect. Immun. 1995; 63: 1142-4.
42. Lacasse M, Fortier C, Chakir J, Cote L, Deslauriers N. Acquired resistance and persistence of Candida albicans following oral candidiasis in the mouse: a model of the carrier state in humans. Oral Microbiol. Immunol. 1993; 8: 313-8.
43. Chakir J, Cote L, Coulombe C, Deslauriers N. Differential pattern of infection and immune response during experimental oral candidiasis in BALB/c and DBA/2 (H-2d) mice. Oral Microbiol. Immunol. 1994; 9: 88-94.
44. Deslauriers N, Coulombe C, Carre B, Goulet JP. Topical application of a corticosteroid destabilizes the host-parasite relationship in an experimental model of the oral carrier state of Candida albicans. FEMS Immunol. Med. Microbiol. 1995; 11: 45-55.
45. Elahi S, Pang G, Clancy R, Ashman RB. Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis. Infect. Immun. 2000; 68: 5771-7.
46. Romani L, Mencacci A, Grohmann U et al. Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J. Exp. Med. 1992; 176: 19-25.
47. Jones-Carson J, Vazquez-Torres A, Balish E. Defective killing of Candida albicans hyphae by neutrophils from beige mice. J. Infect. Dis 1995; 171: 1664-7.
48. Elahi S, Pang G, Ashman RB, Clancy R. Nitric oxide-enhanced resistance to oral candidiasis. Immunology 2001; 104: 447-54.
49. Ashman RB, Papadimitriou JM. Murine candidiasis. Pathogenesis and host responses in genetically distinct inbred mice. Immunol. Cell Biol. 1987; 65: 163-71.
50. Ashman RB. A gene (Cargl) that regulates tissue resistance to Candida albicans maps to chromosome 14 of the mouse. Microb. Pathog. 1998; 25: 333-5.
51. Farah CS, Hong S, Wanasaengsakul S et al. Irradiation-induced oral candidiasis in an experimental murine model. Oral Microbiol. Immunol. 2001; 16: 358-63.
52. Farah CS, Elahi S, Pang G et al. T cells augment monocyte and neutrophil function in host resistance against oropharyngeal candidiasis. Infect. Immun. 2001; 69: 6110-8.
53. Farah CS, Gotjamanos T, Seymour GJ, Ashman RB. Cytokines in the oral mucosa of mice infected with Candida albicans. Oral Microbiol. Immunol. 2003; 17: 375-8.
54. Balish E, Wagner RD, Vazquez-Torres A, Pierson C, Warner T. Candidiasis in interferon-gamma knockout (IFN-γ (-/-) mice. J. Infect. Dis 1998; 178: 478-87.
55. Qian QF, Cutler JE. Gamma interferon is not essential in host defense against disseminated candidiasis in mice. Infect. Immun. 1997; 65: 1748-53.
56. Kaposzta R, Tree P, Marodi L, Gordon S. Characteristics of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice - role of macrophages in host defence against Candida albicans. Infect. Immun. 1998; 66: 1708-17.
57. Del Sero G, Mencacci A, Cenci E et al. Antifungal type 1 responses are upregulated in il-10-deficient mice. Microb. Infect. 1999; 1: 1169-80.
58. Vazquez-Torres A, Jones-Carson J, Wagner RD, Warner T, Balish E. Early resistance of interleukin-10 knockout mice to acute systemic candidiasis. Infect. Immun. 1999; 67: 670-4.
59. Ashman RB, Papadimitriou JM, Fulurija A et al. Role of complement C5 and T lymphocytes in pathogenesis of disseminated and mucosal candidiasis in susceptible DBA/2 mice. Microb. Pathog. 2003; 34: 103-13.
60. Ashman RB. Mouse candidiasis. Ii. Host responses are T-cell dependent and regulated by genes in the major histocompatibility complex. Immunogenetics 1987; 25: 200-3.
61. Ashman RB, Bolitho EM, Papadimitriou JM. Patterns of resistance to Candida albicans in inbred mouse strains. Immunol. Cell Biol. 1993; 71: 221-5.
62. Ashman RB, Papadimitriou JM. Genetic resistance to Candida albicans infection is conferred by cells derived from the bone marrow. J. Infect. Dis 1992; 166: 947-8.
63. Fulurija A, Ashman RB, Papadimitriou JM. Increased tissue resistance in the nude mouse against Candida albicans without altering strain-dependent differences in susceptibility. J. Med. Vet. Mycol. 1997; 35: 197-203.
64. Hector RF, Domer JE, Carrow EW. Immune responses to Candida albicans in genetically distinct mice. Infect. Immun. 1982; 38: 1020-8.
65. Ashman RB, Bolitho EM. Strain differences in the severity of lesions in murine systemic candidiasis correlate with the production of functional gamma interferon by candida-activated lymphocytes in vitro. Lymphokine Cytokine Res. 1993; 12: 471-6.
66. Lyon FL, Hector RF, Domer JE. Innate and acquired immune responses against candida albicans in congenic B10.D2 mice with deficiency of the C5 complement component. J. Med. Vet. Mycol. 1986; 24: 359-67.
67. Ashman RB, Fulurija A, Papadimitriou JM. Strain-dependent differences in host response to Candida albicans infection in mice are related to organ susceptibility and infectious load. Infect. Immun. 1996; 64: 1866-9.
68. Morelli R, Rosenberg LT. The role of complement in the phagocytosis of Candida albicans by mouse peripheral blood leukocytes. J. Immunol. 1971; 107: 476-80.
69. + subset expression in murine candidiasis. Infect. Immun. 1992; 60: 4950-2.
70. Cheers C, Waller R. Activated macrophages in congenitally athymic 'nude' and in lethally irradiated mice. J. Immunol. 1975; 115: 844-7.
71. Rogers TJ, Balish E. The role of activated macrophages in resistance to experimental renal candidiasis. J. Reticuloendothel. Soc. 1977; 22: 309-18.
72. Ashman RB. Murine candidiasis: Cell-mediated immune responses correlate directly with susceptibility and resistance to infection. Immunol. Cell Biol. 1990; 68: 15-20.
73. Spellberg B, Johnston D, Phan QT et al. Parenchymal organ, and not splenic, immunity correlates with host survival during disseminated candidiasis. Infect. Immun. 2003; 71: 5756-64.
74. + regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J. Immunol. 2002; 169: 6298-308.
75. Ashman RB. Murine candidiasis. Susceptibility is associated with the induction of T cell-mediated, strain-specific autoreactivity. Immunol. Cell Biol. 1990; 68: 179-85.